Asia Pacific Pharmaceutical Logistics Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Market Size (2024) | USD 152.79 Billion |
| Market Size (2029) | USD 211.16 Billion |
| CAGR (2024 - 2029) | 6.68 % |
| Market Concentration | Low |
Major Players_-_Copy.webp "Asia-Pacific Pharmaceutical Logistics Market Major Players")
*Disclaimer: Major Players sorted in no particular order |
Asia Pacific Pharmaceutical Logistics Market Analysis
The Asia-Pacific Pharmaceutical Logistics Market size is estimated at USD 152.79 billion in 2024, and is expected to reach USD 211.16 billion by 2029, growing at a CAGR of 6.68% during the forecast period (2024-2029).
- The Asia-Pacific Pharmaceutical Logistics Market is rapidly growing due to the increasing drug demand from emerging countries. The number of patients in developed and developing regions is increasing rapidly, which in turn is impacting the existing pharmaceutical distribution channels. This has led to an increased demand for logistics services provided by pharma companies to meet this increasing need for supply management solutions.
- The Asia-Pacific Pharmaceutical Logistics Market is the fastest-growing market in the pharmaceutical industry. The demand for pharmaceutical logistics services has been on the rise in recent times, emerging as a strategic business for drug manufacturers, distributors, retailers, and other players involved in the supply chain management of drugs.
- The rise in demand is due to increasing healthcare expenditure across the region, coupled with the growing use of generic substitutes and increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular ailments like hypertension which are associated with high treatment costs.
- The Asia Pacific Pharmacy Logistics Market is driven by the growth in demand for herbal drugs in developing markets such as China, India, and Japan, along with the increase in prescriptions across developed economies such as Australia, Hong Kong, South Korea, and Singapore.
- Due to the COVID-19 pandemic's effects on the healthcare cold chain industry's supply chain and the pandemic's restrictions on commerce, cold chain manufacturers focused more on storage to extend their products' shelf lives, which was expected to fuel the market for cold chain expansion.
Asia Pacific Pharmaceutical Logistics Market Trends
Cold chain Logistics is driving the market
Due to the COVID-19 pandemic's effects on the healthcare cold chain industry's supply chain and the pandemic's restrictions on commerce, cold chain manufacturers focused more on storage to extend their products' shelf lives, which was expected to fuel the market for cold chain expansion.
Healthcare spending in the region is growing quickly due to an aging population and rising disposable incomes. It will continue to be crucial to the prospects of global pharmaceutical and biotechnology companies. India, China, Singapore, South Korea, and other countries in the Asia-Pacific region are quickly becoming important hubs for the outsourcing of pathology testing, drug manufacturing, and clinical trials.
This has increased the demand for temperature-sensitive healthcare products, such as vaccinations, biopharmaceuticals, and clinical trial materials. These changes have fueled the Asia-Pacific region's demand for cold storage facilities and supported more investments in ongoing infrastructure upgrades. The healthcare cold chain logistics services are being improved by the governments of various Asian nations.
The demand for biopharmaceuticals and vaccines, which require cold chains, is rising. Stricter government restrictions are also to blame for the efficient handling of temperature-sensitive pharmaceutical items.
The demand for healthcare cold chain logistics is also fueled by the booming pharmaceutical industry, which is developing to meet the healthcare needs of the expanding population. Factors limiting market expansion include a lack of consistency in operating processes, security, temperature, pest management, and expensive operational costs.
China Leads the Asia-Pacific Region with Highest Market Capitalization
In terms of market value, China was in the top 50 Asia-Pacific (APAC) pharmaceutical companies during the first quarter of 2021. Compared to Q4 2020, the 50 APAC companies' combined market capitalization increased by 3.8% at the end of Q1 2021, with 28 Chinese companies making up 60% of the total. The pharmaceutical industry in Japan is growing to become the second-largest in the world. Over the years, foreign direct investments (FDI) have gradually expanded in the Japanese pharmaceutical industry, helping the nation build a global presence. Four of the top 25 pharmaceutical businesses in the world are headquartered in Japan.
The market is expanding due to increased demand for efficient cold-chain logistics services to maintain the quality of goods. Additionally, the logistics and cold chain for the pharmaceutical business are becoming more strategic and dependable. The majority of high-value pharmaceutical items are distributed throughout the whole distribution network using cold chain solutions, which is what is fueling the market's expansion in the Asia-Pacific region.
Asia Pacific Pharmaceutical Logistics Industry Overview
The market for pharmaceutical logistics in the Asia-Pacific region is highly competitive and fragmented, with many participants. A secure supply chain function and cloud-based supply chain solutions are priorities for many businesses. These technical advancements assist manufacturers in determining the legitimacy of the drugs, preventing the development of fake pharmaceuticals and medical equipment. To increase their geographic reach and access to proprietary knowledge, many businesses engage in merger and acquisition activities.
Additionally, they want to lower the total cost of packaging their goods. Kuehne + Nagel, DB Schenker, DHL, DSV Panalpina, FedEx, Bio Pharma Logistics, Kerry Logistics, Genco, Arich Enterprise Co., Ltd, Mainfreight Ltd, Thermotraffic, Bestchain Healthtaiwan, Movianto, and Zuellig Pharma Asia Pacific Ltd. are a few of the leading businesses currently operating in the market.
Asia Pacific Pharmaceutical Logistics Market Leaders
-
Kuehne + Nagel
-
DSV Panalpina
-
Bio Pharma Logistics
-
DB Schenker
-
DHL
*Disclaimer: Major Players sorted in no particular order
Asia Pacific Pharmaceutical Logistics Market News
- December 2022: DHL Supply Chain has disclosed its Northern Taiwan plant growth plans for five years. The investment of EUR 10 million (USD 10515247.1083) would expand DHL Supply Chain's market reach and meet the logistics needs of the LSHC and semiconductor industries. The newly inaugurated Taoyuan Distribution Center-Jian Guo, DHL Supply Chain's second location in Taoyuan, is a part of the development.
- August 2022: To bolster its efforts in China's pharmaceutical industry, Nippon Express (China) Co., Ltd., a group subsidiary of NIPPON EXPRESS HOLDINGS, INC., launched a Healthcare Branch in Shanghai. This new branch began operations on July 1.
Asia Pacific Pharmaceutical Logistics Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Deliverables
- 1.2 Study Assumptions
- 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
- 2.1 Analysis Methodology
- 2.2 Research Phases
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS
- 4.1 Current Market Scenario
- 4.2 Pharmaceutical Value Chain / Supply Chain Analysis
- 4.3 Technological Trends
- 4.4 Investment Scenarios
- 4.5 Government Regulations and Initiatives
- 4.6 Insights on 3PL market in Asia-Pacific
- 4.7 Impact of COVID-19 on Pharmaceutical Logistics Market
5. MARKET DYNAMICS
- 5.1 Drivers
- 5.2 Restraints
- 5.3 Opportunities
-
5.4 Industry Attractiveness - Porter's Five Forces Analysis
- 5.4.1 Bargaining Power of Suppliers
- 5.4.2 Bargaining Power of Consumers
- 5.4.3 Threat of New Entrants
- 5.4.4 Threat of Substitutes
- 5.4.5 Intensity of Competitive Rivalry
6. MARKET SEGMENTATION
-
6.1 By Product
- 6.1.1 Generic Drugs
- 6.1.2 Branded Drugs
-
6.2 By Mode of Operation
- 6.2.1 Cold Chain Transport
- 6.2.2 Non-Cold Chain Transport
-
6.3 By Application
- 6.3.1 Bio Pharma
- 6.3.2 Chemical Pharma
- 6.3.3 Specialized Pharma
-
6.4 By Mode of Transport
- 6.4.1 Air
- 6.4.2 Rail
- 6.4.3 Road
- 6.4.4 Sea
-
6.5 By Geography
- 6.5.1 China
- 6.5.2 India
- 6.5.3 Japan
- 6.5.4 South Korea
- 6.5.5 Singapore
- 6.5.6 Australia
- 6.5.7 Rest of Asia Pacific
7. COMPETITIVE LANDSCAPE
- 7.1 Market Concentration Overview
-
7.2 Company Profiles
- 7.2.1 Kuehne + Nagel
- 7.2.2 DB Schenker
- 7.2.3 DHL
- 7.2.4 DSV Panalpina
- 7.2.5 FedEx
- 7.2.6 Bio Pharma Logistics
- 7.2.7 Kerry Logistics
- 7.2.8 Genco
- 7.2.9 Arich Enterprise Co., Ltd
- 7.2.10 Mainfreight Ltd
- 7.2.11 Thermotraffic
- 7.2.12 Bestchain Healthtaiwan
- 7.2.13 CEVA Logistics
- 7.2.14 UPS*
- *List Not Exhaustive
8. MARKET OPPORTUNITIES AND FUTURE TRENDS
9. APPENDIX
** Subject To AvailablityAsia Pacific Pharmaceutical Logistics Industry Segmentation
Pharmaceutical logistics is a method the healthcare system uses to ensure consistent support, a supply of medical tools and assistance, waste removal, cleaning, sterilization, and other relevant support activities for the control process.
Asia-Pacific Pharmaceutical Logistics Market report provides insights into the market Market Overview, Market Dynamics, Pharmaceutical Value Chain / Supply Chain Analysis, Technological Trends, Investment Scenarios, Government Regulations and Initiatives, Insights on the 3PL market in Asia-Pacific (Market Size and Forecast), Impact of Covid-19 on Pharmaceutical Logistics Market and Industry Attractiveness - Porter's Five Forces Analysis.
The Asia-Pacific Pharmaceutical Logistics market is segmented by product (Generic Drugs, Branded Drugs), by mode of operation (Cold Chain Transport, Non-Cold Chain Transport), by application (Bio Pharma, Chemical Pharma, Specialized Pharma), by mode of transport (Air, Rail, Road, and Sea) and by geography (China, India, Japan, South Korea, Singapore, Australia, and Rest of APAC). The report offers market size and forecast for Asia-Pacific Pharmaceutical Logistics Market in value (USD billion) for all the above segments.
| By Product | Generic Drugs |
| Branded Drugs | |
| By Mode of Operation | Cold Chain Transport |
| Non-Cold Chain Transport | |
| By Application | Bio Pharma |
| Chemical Pharma | |
| Specialized Pharma | |
| By Mode of Transport | Air |
| Rail | |
| Road | |
| Sea | |
| By Geography | China |
| India | |
| Japan | |
| South Korea | |
| Singapore | |
| Australia | |
| Rest of Asia Pacific |
Asia Pacific Pharmaceutical Logistics Market Research FAQs
How big is the Asia-Pacific Pharmaceutical Logistics Market?
The Asia-Pacific Pharmaceutical Logistics Market size is expected to reach USD 152.79 billion in 2024 and grow at a CAGR of 6.68% to reach USD 211.16 billion by 2029.
What is the current Asia-Pacific Pharmaceutical Logistics Market size?
In 2024, the Asia-Pacific Pharmaceutical Logistics Market size is expected to reach USD 152.79 billion.
Who are the key players in Asia-Pacific Pharmaceutical Logistics Market?
Kuehne + Nagel, DSV Panalpina, Bio Pharma Logistics, DB Schenker and DHL are the major companies operating in the Asia-Pacific Pharmaceutical Logistics Market.
What years does this Asia-Pacific Pharmaceutical Logistics Market cover, and what was the market size in 2023?
In 2023, the Asia-Pacific Pharmaceutical Logistics Market size was estimated at USD 143.22 billion. The report covers the Asia-Pacific Pharmaceutical Logistics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia-Pacific Pharmaceutical Logistics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Asia Pacific Pharmaceutical Logistics Industry Report
Statistics for the 2024 Asia Pacific Pharmaceutical Logistics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Asia Pacific Pharmaceutical Logistics analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
